Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Sagimet Biosciences Inc. (SGMT) Non-Performing Assets / Total Loans data is not available.
Income Statement Financials | |
-- |
|
$-45.57M |
|
-- |
|
-- |
|
$54.45M |
|
$-54.45M |
|
$8.89M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-54.45M |
|
$-55.71M |
|
31.35M |
|
31.35M |
|
$-1.45 |
|
$-1.45 |
|
Balance Sheet Financials | |
$152.77M |
|
-- |
|
$7.49M |
|
$160.26M |
|
$4.45M |
|
-- |
|
-- |
|
$4.45M |
|
$155.81M |
|
$155.81M |
|
$155.81M |
|
32.20M |
|
Cash Flow Statement Financials | |
$-42.44M |
|
$-61.68M |
|
$104.82M |
|
$75.14M |
|
$75.84M |
|
$0.70M |
|
$5.29M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
34.30 |
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.25% |
|
-29.25% |
|
-28.43% |
|
-29.25% |
|
$4.84 |
|
$-1.35 |
|
$-1.35 |